Multiple daily-dose pharmacokinetics of lisdexamfetamine dimesylate in healthy adult volunteers.
about
Amphetamine, past and present--a pharmacological and clinical perspectiveADHD in Children Onset of Efficacy of Long-Acting Psychostimulants in Pediatric Attention-Deficit/Hyperactivity DisorderLisdexamfetamine Dimesylate: Prodrug Delivery, Amphetamine Exposure and Duration of EfficacyUpdate on optimal use of lisdexamfetamine in the treatment of ADHD.Update on the management of attention-deficit/hyperactivity disorder in children and adults: patient considerations and the role of lisdexamfetamine.Lisdexamfetamine dimesylate: a new therapeutic option for attention-deficit hyperactivity disorder.Focus on Lisdexamfetamine: A Review of its use in Child and Adolescent Psychiatry.Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day.Effects of omeprazole on the pharmacokinetic profiles of lisdexamfetamine dimesylate and extended-release mixed amphetamine salts in adults.Agonist replacement therapy for cocaine dependence: a translational review.Method validation and determination of lisdexamfetamine and amphetamine in oral fluid, plasma and urine by LC-MS/MS.Study protocol: a dose-escalating, phase-2 study of oral lisdexamfetamine in adults with methamphetamine dependencePharmacokinetics of coadministered guanfacine extended release and lisdexamfetamine dimesylate.A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder.Lisdexamfetamine for treatment of attention-deficit/hyperactivity disorder.Relative Bioavailabilities of Lisdexamfetamine Dimesylate and D-Amphetamine in Healthy Adults in an Open-Label, Randomized, Crossover Study After Mixing Lisdexamfetamine Dimesylate With Food or DrinkPharmacokinetic variability of long-acting stimulants in the treatment of children and adults with attention-deficit hyperactivity disorder.An update on lisdexamfetamine dimesylate for the treatment of attention deficit hyperactivity disorder.The use of lisdexamfetamine dimesylate for the treatment of ADHD and other psychiatric disorders.Lisdexamfetamine for binge eating disorder in adults: a systematic review of the efficacy and safety profile for this newly approved indication - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?Lisdexamfetamine: A Review in ADHD in Adults.Pharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects.Intranasal versus oral administration of lisdexamfetamine dimesylate: a randomized, open-label, two-period, crossover, single-dose, single-centre pharmacokinetic study in healthy adult men.Lisdexamfetamine dimesylate: linear dose-proportionality, low intersubject and intrasubject variability, and safety in an open-label single-dose pharmacokinetic study in healthy adult volunteers.Isotope-dilution mass spectrometric quantification of the prodrug lisdexamfetamine in human urine in doping control analysis.Lisdexamfetamine dimesylate: in attention-deficit hyperactivity disorder in adults.
P2860
Q22241826-06160120-7487-4DDD-ACF4-238978DD982AQ22305481-126959DE-A6A4-4F1D-A352-F7EAACB52C21Q26750486-E4D55578-24ED-4637-9710-D1E8BAC90020Q30418053-FC220C01-AEB8-4CE0-B839-C25848E9934FQ33571016-C8D44F20-570D-42FA-8C58-310B1A691160Q34032634-767E63ED-948E-4F9A-9CCA-F918E8CD06C5Q34232286-05D8885C-6A13-4424-828F-958FD45E16D7Q34498667-DB9B2C61-F719-4115-88DF-4AB42EE6E39CQ35007442-C027E329-322E-48AF-88E3-36F3D20A7667Q35799846-0486E862-B811-4825-819E-34033C727A00Q36102896-A3168B23-36C2-4EA3-AC8E-5A3BA93CD303Q36209156-DF74ED41-26CB-4BCB-AE00-16ADE1DA9367Q36947618-C57A53C3-F1DF-48AD-BE07-3FD6E72D140BQ37246370-E07CC322-D95C-46BB-99D1-124DE89BB22FQ37422844-935B26E0-B9C2-4ED4-BE0A-D15752DB8453Q37506129-7C8C41D2-3F7C-4297-86F7-5094FDE17406Q37810900-B6009369-38F7-4E7F-B144-8756FFD76EE0Q38067497-833377E1-230E-496F-9DC1-FB635511F153Q38221823-862D3E62-BD03-41F2-9FEF-041132AF1EBDQ38370764-71EBE82D-64C1-4B9B-95A1-4A8C886277F5Q38799006-C5C460DC-504B-42EA-B085-5F75122F96B9Q41312831-CC3B7BB0-3505-41E1-AE9F-0B7EB101944BQ42599423-B156CED8-675C-4DB7-A9E3-77A05E847FFDQ43155088-6A40CF10-1D21-4166-976A-051A0DE8B016Q45012725-97574252-9E2B-4E78-B156-A6B69C72C226Q46005804-E929D1FB-2F3D-495E-B24F-1E06A4292E9E
P2860
Multiple daily-dose pharmacokinetics of lisdexamfetamine dimesylate in healthy adult volunteers.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Multiple daily-dose pharmacoki ...... e in healthy adult volunteers.
@en
Multiple daily-dose pharmacoki ...... e in healthy adult volunteers.
@nl
type
label
Multiple daily-dose pharmacoki ...... e in healthy adult volunteers.
@en
Multiple daily-dose pharmacoki ...... e in healthy adult volunteers.
@nl
prefLabel
Multiple daily-dose pharmacoki ...... e in healthy adult volunteers.
@en
Multiple daily-dose pharmacoki ...... e in healthy adult volunteers.
@nl
P356
P1476
Multiple daily-dose pharmacoki ...... e in healthy adult volunteers.
@en
P2093
Jeffrey G Stark
Suma M Krishnan
P356
10.1185/030079908X242737
P407
P577
2008-01-01T00:00:00Z